A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
Approximately 300 patients will be entered into this study taking place throughout the United
States, Canada and the United Kingdom. This study aims to determine if an investigational
drug is safe and effective for treating the symptoms of C. difficile-associated diarrhea and
lowering the risk of repeat episodes of diarrhea. The investigational drug will be evaluated
in comparison to current standard antibiotic treatment, so all patients will receive active
medication.
All study-related care is provided including doctor visits, physical exams, laboratory tests
and study medication. Total length of participation is approximately 10 weeks.